Misplaced Pages

Toxicology

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.
(Redirected from History of toxicology) Study of substances harmful to living organisms For the scientific journal, see Toxicology (journal).

A toxicologist working in a lab (United States, 2008)

Toxicology is a scientific discipline, overlapping with biology, chemistry, pharmacology, and medicine, that involves the study of the adverse effects of chemical substances on living organisms and the practice of diagnosing and treating exposures to toxins and toxicants. The relationship between dose and its effects on the exposed organism is of high significance in toxicology. Factors that influence chemical toxicity include the dosage, duration of exposure (whether it is acute or chronic), route of exposure, species, age, sex, and environment. Toxicologists are experts on poisons and poisoning. There is a movement for evidence-based toxicology as part of the larger movement towards evidence-based practices. Toxicology is currently contributing to the field of cancer research, since some toxins can be used as drugs for killing tumor cells. One prime example of this is ribosome-inactivating proteins, tested in the treatment of leukemia.

The word toxicology (/ˌtɒksɪˈkɒlədʒi/) is a neoclassical compound from Neo-Latin, first attested c. 1799, from the combining forms toxico- + -logy, which in turn come from the Ancient Greek words τοξικός toxikos, "poisonous", and λόγος logos, "subject matter").

History

Folio from the Kalpasthāna (Dundhubhisvanīya chapter), from a manuscript of the Śuśrutasaṃhitā, Nepal, 878 CE.

The earliest treatise dedicated to the general study of plant and animal poisons, including their classification, recognition, and the treatment of their effects is the Kalpasthāna, one of the major sections of the Suśrutasaṃhitā, a Sanskrit work composed before ca. 300 CE and perhaps in part as early as the fourth century BCE. The Kalpasthāna was influential on many later Sanskrit medical works and was translated into Arabic and other languages, influencing South East Asia, the Middle East, Tibet and eventually Europe.

Dioscorides, a Greek physician in the court of the Roman emperor Nero, made an early attempt to classify plants according to their toxic and therapeutic effect. A work attributed to the 10th century author Ibn Wahshiyya called the Book on Poisons describes various toxic substances and poisonous recipes that can be made using magic. A 14th century Kannada poetic work attributed to the Jain prince Mangarasa, Khagendra Mani Darpana, describes several poisonous plants.

Lithograph of Mathieu Orfila

The 16th-century Swiss physician Paracelsus is considered "the father" of modern toxicology, based on his rigorous (for the time) approach to understanding the effects of substances on the body. He is credited with the classic toxicology maxim, "Alle Dinge sind Gift und nichts ist ohne Gift; allein die Dosis macht, dass ein Ding kein Gift ist." which translates as, "All things are poisonous and nothing is without poison; only the dose makes a thing not poisonous." This is often condensed to: "The dose makes the poison" or in Latin "Sola dosis facit venenum".

Mathieu Orfila is also considered the modern father of toxicology, having given the subject its first formal treatment in 1813 in his Traité des poisons, also called Toxicologie générale.

In 1850, Jean Stas became the first person to successfully isolate plant poisons from human tissue. This allowed him to identify the use of nicotine as a poison in the Bocarmé murder case, providing the evidence needed to convict the Belgian Count Hippolyte Visart de Bocarmé of killing his brother-in-law.

Basic principles

The goal of toxicity assessment is to identify adverse effects of a substance. Adverse effects depend on two main factors: i) routes of exposure (oral, inhalation, or dermal) and ii) dose (duration and concentration of exposure). To explore dose, substances are tested in both acute and chronic models. Generally, different sets of experiments are conducted to determine whether a substance causes cancer and to examine other forms of toxicity.

Factors that influence chemical toxicity:

  • Dosage
    • Both large single exposures (acute) and continuous small exposures (chronic) are studied.
  • Route of exposure
    • Ingestion, inhalation or skin absorption
  • Other factors
    • Species
    • Age
    • Sex
    • Health
    • Environment
    • Individual characteristics

The discipline of evidence-based toxicology strives to transparently, consistently, and objectively assess available scientific evidence in order to answer questions in toxicology, the study of the adverse effects of chemical, physical, or biological agents on living organisms and the environment, including the prevention and amelioration of such effects. Evidence-based toxicology has the potential to address concerns in the toxicological community about the limitations of current approaches to assessing the state of the science. These include concerns related to transparency in decision-making, synthesis of different types of evidence, and the assessment of bias and credibility. Evidence-based toxicology has its roots in the larger movement towards evidence-based practices.

Testing methods

Toxicity experiments may be conducted in vivo (using the whole animal) or in vitro (testing on isolated cells or tissues), or in silico (in a computer simulation).

In vivo model organism

The classic experimental tool of toxicology is testing on non-human animals. Examples of model organisms are Galleria mellonella, which can replace small mammals, Zebrafish (Danio rerio), which allow for the study of toxicology in a lower order vertebrate in vivo and Caenorhabditis elegans. As of 2014, such animal testing provides information that is not available by other means about how substances function in a living organism. The use of non-human animals for toxicology testing is opposed by some organisations for reasons of animal welfare, and it has been restricted or banned under some circumstances in certain regions, such as the testing of cosmetics in the European Union.

In vitro methods

While testing in animal models remains as a method of estimating human effects, there are both ethical and technical concerns with animal testing.

Since the late 1950s, the field of toxicology has sought to reduce or eliminate animal testing under the rubric of "Three Rs" – reduce the number of experiments with animals to the minimum necessary; refine experiments to cause less suffering, and replace in vivo experiments with other types, or use more simple forms of life when possible. The historical development of alternative testing methods in toxicology has been published by Balls.

Computer modeling is an example of an alternative in vitro toxicology testing method; using computer models of chemicals and proteins, structure-activity relationships can be determined, and chemical structures that are likely to bind to, and interfere with, proteins with essential functions, can be identified. This work requires expert knowledge in molecular modeling and statistics together with expert judgment in chemistry, biology and toxicology.

In 2007 the American NGO National Academy of Sciences published a report called "Toxicity Testing in the 21st Century: A Vision and a Strategy" which opened with a statement: "Change often involves a pivotal event that builds on previous history and opens the door to a new era. Pivotal events in science include the discovery of penicillin, the elucidation of the DNA double helix, and the development of computers. ... Toxicity testing is approaching such a scientific pivot point. It is poised to take advantage of the revolutions in biology and biotechnology. Advances in toxicogenomics, bioinformatics, systems biology, epigenetics, and computational toxicology could transform toxicity testing from a system based on whole-animal testing to one founded primarily on in vitro methods that evaluate changes in biologic processes using cells, cell lines, or cellular components, preferably of human origin." As of 2014 that vision was still unrealized.

The United States Environmental Protection Agency studied 1,065 chemical and drug substances in their ToxCast program (part of the CompTox Chemicals Dashboard) using in silica modelling and a human pluripotent stem cell-based assay to predict in vivo developmental intoxicants based on changes in cellular metabolism following chemical exposure. Major findings from the analysis of this ToxCast_STM dataset published in 2020 include: (1) 19% of 1065 chemicals yielded a prediction of developmental toxicity, (2) assay performance reached 79%–82% accuracy with high specificity (> 84%) but modest sensitivity (< 67%) when compared with in vivo animal models of human prenatal developmental toxicity, (3) sensitivity improved as more stringent weights of evidence requirements were applied to the animal studies, and (4) statistical analysis of the most potent chemical hits on specific biochemical targets in ToxCast revealed positive and negative associations with the STM response, providing insights into the mechanistic underpinnings of the targeted endpoint and its biological domain.

In some cases shifts away from animal studies have been mandated by law or regulation; the European Union (EU) prohibited use of animal testing for cosmetics in 2013.

Dose response complexities

Most chemicals display a classic dose response curve – at a low dose (below a threshold), no effect is observed. Some show a phenomenon known as sufficient challenge – a small exposure produces animals that "grow more rapidly, have better general appearance and coat quality, have fewer tumors, and live longer than the control animals". A few chemicals have no well-defined safe level of exposure. These are treated with special care. Some chemicals are subject to bioaccumulation as they are stored in rather than being excreted from the body; these also receive special consideration.

Several measures are commonly used to describe toxic dosages according to the degree of effect on an organism or a population, and some are specifically defined by various laws or organizational usage. These include:

  • LD50 or LD50 = Median lethal dose, a dose that will kill 50% of an exposed population
  • NOEL = No-Observed-Effect-Level, the highest dose known to show no effect
  • NOAEL = No-Observed-Adverse-Effect-Level, the highest dose known to show no adverse effects
  • PEL = Permissible Exposure Limit, the highest concentration permitted under US OSHA regulations
  • STEL = Short-Term Exposure Limit, the highest concentration permitted for short periods of time, in general 15–30 minutes
  • TWA = Time-Weighted Average, the average amount of an agent's concentration over a specified period of time, usually 8 hours
  • TTC = The Threshold of Toxicological Concern concept has been applied to low-level contaminants, such as the constituents of tobacco smoke

Types

"Clinical toxicology" redirects here. For the journal, see Clinical Toxicology.
Brochure illustrating the work of the CDC Division of Laboratory Sciences

Medical toxicology is the discipline that requires physician status (MD or DO degree plus specialty education and experience).

Clinical toxicology is the discipline that can be practiced not only by physicians but also other health professionals with a master's degree in clinical toxicology: physician extenders (physician assistants, nurse practitioners), nurses, pharmacists, and allied health professionals.

Forensic toxicology is the discipline that makes use of toxicology and other disciplines such as analytical chemistry, pharmacology and clinical chemistry to aid medical or legal investigation of death, poisoning, and drug use. The primary concern for forensic toxicology is not the legal outcome of the toxicological investigation or the technology utilized, but rather the obtainment and interpretation of results.

Computational toxicology is a discipline that develops mathematical and computer-based models to better understand and predict adverse health effects caused by chemicals, such as environmental pollutants and pharmaceuticals. Within the Toxicology in the 21st Century project, the best predictive models were identified to be Deep Neural Networks, Random Forest, and Support Vector Machines, which can reach the performance of in vitro experiments.

Occupational toxicology is the application of toxicology to chemical hazards in the workplace.

Toxicology as a profession

This section does not cite any sources. Please help improve this section by adding citations to reliable sources. Unsourced material may be challenged and removed. (June 2014) (Learn how and when to remove this message)

A toxicologist is a scientist or medical personnel who specializes in the study of symptoms, mechanisms, treatments and detection of venoms and toxins; especially the poisoning of people.

Requirements

To work as a toxicologist one should obtain a degree in toxicology or a related degree like biology, chemistry, pharmacology or biochemistry. Bachelor's degree programs in toxicology cover the chemical makeup of toxins and their effects on biochemistry, physiology and ecology. After introductory life science courses are complete, students typically enroll in labs and apply toxicology principles to research and other studies. Advanced students delve into specific sectors, like the pharmaceutical industry or law enforcement, which apply methods of toxicology in their work. The Society of Toxicology (SOT) recommends that undergraduates in postsecondary schools that do not offer a bachelor's degree in toxicology consider attaining a degree in biology or chemistry. Additionally, the SOT advises aspiring toxicologists to take statistics and mathematics courses, as well as gain laboratory experience through lab courses, student research projects and internships. To become Medical Toxicologists, physicians in the United States complete residency training such as in Emergency Medicine, Pediatrics or Internal Medicine, followed by fellowship in Medical Toxicology and eventual certification by the American College of Medical Toxicology (ACMT).

Duties

Toxicologists perform many different duties including research in the academic, nonprofit and industrial fields, product safety evaluation, consulting, public service and legal regulation. In order to research and assess the effects of chemicals, toxicologists perform carefully designed studies and experiments. These experiments help identify the specific amount of a chemical that may cause harm and potential risks of being near or using products that contain certain chemicals. Research projects may range from assessing the effects of toxic pollutants on the environment to evaluating how the human immune system responds to chemical compounds within pharmaceutical drugs. While the basic duties of toxicologists are to determine the effects of chemicals on organisms and their surroundings, specific job duties may vary based on industry and employment. For example, forensic toxicologists may look for toxic substances in a crime scene, whereas aquatic toxicologists may analyze the toxicity level of water bodies.

Compensation

The salary for jobs in toxicology is dependent on several factors, including level of schooling, specialization, experience. The U.S. Bureau of Labor Statistics (BLS) notes that jobs for biological scientists, which generally include toxicologists, were expected to increase by 21% between 2008 and 2018. The BLS notes that this increase could be due to research and development growth in biotechnology, as well as budget increases for basic and medical research in biological science.

See also

References

  1. Schrager TF (October 4, 2006). "What is Toxicology". Archived from the original on March 10, 2007.
  2. Mercatelli D, Bortolotti M, Giorgi FM (August 2020). "Transcriptional network inference and master regulator analysis of the response to ribosome-inactivating proteins in leukemia cells". Toxicology. 441: 152531. Bibcode:2020Toxgy.44152531M. doi:10.1016/j.tox.2020.152531. PMID 32593706. S2CID 220255474.
  3. Merriam-Webster, Merriam-Webster's Unabridged Dictionary, Merriam-Webster, archived from the original on 2020-05-25, retrieved 2017-07-28.
  4. Meulenbeld GJ (1999). A history of Indian medical literature. Groningen Oriental studies. Vol. IA. Groningen: E. Forsten. pp. 289–299. ISBN 978-90-6980-124-7. OCLC 42207455.
  5. Wujastyk D, ed. (2003). The roots of Ayurveda: selections from Sanskrit medical writings. Penguin classics (3 ed.). London: Penguin Books. pp. 78–81, 131–146. ISBN 978-0-14-044824-5.
  6. Meulenbeld GJ (1999). A history of Indian medical literature. Groningen Oriental studies. Vol. IA. Groningen: E. Forsten. p. 352. ISBN 978-90-6980-124-7. OCLC 42207455.
  7. Strauss B (1934). "Das Giftbuch des Śānāq: eine Literaturgeschichtliche Untersuchung". Quellen und Studien zur Geschichte der Naturwissenschaften und der Medizin. 4 (2): 89--152 followed by Arabic text.
  8. Hodgson E (2010). A Textbook of Modern Toxicology. John Wiley and Sons. p. 10. ISBN 978-0-470-46206-5.
  9. Levey M (2017). Arnold E, Flood FB, Necipoğlu G (eds.). A Companion to Islamic Art and Architecture. Wiley. pp. 525–526. ISBN 978-1-119-06857-0.
  10. Bhat S, Udupa K (August 2013). "Taxonomical outlines of bio-diversity of Karnataka in a 14th century Kannada toxicology text Khagendra Mani Darpana". Asian Pacific Journal of Tropical Biomedicine. 3 (8): 668–72, discussion 672. doi:10.1016/S2221-1691(13)60134-3. PMC 3703563. PMID 23905027.
  11. "Paracelsus Dose Response in the Handbook of Pesticide Toxicology WILLIAM C KRIEGER / Academic Press Oct01".
  12. ^ Ottoboni MA (1991). The dose makes the poison: a plain-language guide to toxicology (2nd ed.). New York, N.Y: Van Nostrand Reinhold. ISBN 978-0-442-00660-0.
  13. "Biography of Mathieu Joseph Bonaventure Orfila (1787–1853)". U.S. National Library of Medicine.
  14. Wennig R (April 2009). "Back to the roots of modern analytical toxicology: Jean Servais Stas and the Bocarmé murder case". Drug Testing and Analysis. 1 (4): 153–155. doi:10.1002/dta.32. PMID 20355192.
  15. Committee on Risk Assessment of Hazardous Air Pollutants, Commission on Life Sciences, National Research Council (1994). Science and judgement in risk assessment. The National Academic Press. p. 56. ISBN 978-0-309-07490-2.
  16. ^ "Human Health Toxicity Assessment". United States Environmental Protection Agencies.
  17. Hoffmann S, Hartung T (September 2006). "Toward an evidence-based toxicology". Human & Experimental Toxicology. 25 (9): 497–513. Bibcode:2006HETox..25..497H. doi:10.1191/0960327106het648oa. PMID 17017003. S2CID 42202416.
  18. "How do you define toxicology?". Society of Toxicology. Archived from the original on 2013-06-05. Retrieved 2017-06-17.
  19. Stephens ML, Andersen M, Becker RA, Betts K, Boekelheide K, Carney E, et al. (2013). "Evidence-based toxicology for the 21st century: opportunities and challenges". Altex. 30 (1): 74–103. doi:10.14573/altex.2013.1.074. PMID 23338808.
  20. Mandrioli D, Silbergeld EK (January 2016). "Evidence from Toxicology: The Most Essential Science for Prevention". Environmental Health Perspectives. 124 (1): 6–11. doi:10.1289/ehp.1509880. PMC 4710610. PMID 26091173.
  21. Schreider J, Barrow C, Birchfield N, Dearfield K, Devlin D, Henry S, et al. (July 2010). "Enhancing the credibility of decisions based on scientific conclusions: transparency is imperative". Toxicological Sciences. 116 (1): 5–7. doi:10.1093/toxsci/kfq102. PMID 20363830.
  22. Adami HO, Berry SC, Breckenridge CB, Smith LL, Swenberg JA, Trichopoulos D, et al. (August 2011). "Toxicology and epidemiology: improving the science with a framework for combining toxicological and epidemiological evidence to establish causal inference". Toxicological Sciences. 122 (2): 223–234. doi:10.1093/toxsci/kfr113. PMC 3155086. PMID 21561883.
  23. Conrad JW, Becker RA (June 2011). "Enhancing credibility of chemical safety studies: emerging consensus on key assessment criteria". Environmental Health Perspectives. 119 (6): 757–764. doi:10.1289/ehp.1002737. PMC 3114808. PMID 21163723.
  24. de Bruin YB, Eskes C, Langezaal I, Coecke S, Kinsner-Ovaskainen A, Hakkinen PJ (2009). "Testing methods and toxicity assessment (Including alternatives)". Information Resources in Toxicology. Academic Press. pp. 497–514. doi:10.1016/B978-0-12-373593-5.00060-4. ISBN 978-0-12-373593-5.
  25. Harding CR, Schroeder GN, Collins JW, Frankel G (November 2013). "Use of Galleria mellonella as a model organism to study Legionella pneumophila infection". Journal of Visualized Experiments (81): e50964. doi:10.3791/50964. PMC 3923569. PMID 24299965.
  26. Planchart A, Mattingly CJ, Allen D, Ceger P, Casey W, Hinton D, et al. (2016-11-01). "Advancing toxicology research using in vivo high throughput toxicology with small fish models". Altex. 33 (4): 435–452. doi:10.14573/altex.1601281. PMC 5270630. PMID 27328013.
  27. Martin WK, Tennant AH, Conolly RB, Prince K, Stevens JS, DeMarini DM, et al. (January 2019). "High-Throughput Video Processing of Heart Rate Responses in Multiple Wild-type Embryonic Zebrafish per Imaging Field". Scientific Reports. 9 (1): 145. Bibcode:2019NatSR...9..145M. doi:10.1038/s41598-018-35949-5. PMC 6333808. PMID 30644404.
  28. Hunt PR (January 2017). "The C. elegans model in toxicity testing". J. Appl. Toxicol. 37 (1): 50–59. doi:10.1002/jat.3357. PMC 5132335. PMID 27443595.
  29. ^ "The importance of animal in research". Society of Toxicology. 2014. Archived from the original on 2014-12-07.
  30. Kanter J (March 11, 2013). "E.U. Bans Cosmetics With Animal-Tested Ingredients". The New York Times. Retrieved October 26, 2018.
  31. "Existing Non-animal Alternatives". AltTox.org. 8 September 2011.
  32. "Alternative toxicity test methods: reducing, refining and replacing animal use for safety testing" (PDF). Society of Toxicology. Archived from the original (PDF) on 2016-03-04. Retrieved 2014-12-05.
  33. Alan M. Goldberg. The Principles of Humane Experimental Technique: Is It Relevant Today? Altex 27, Special Issue 2010
  34. Balls M, Combes RD, Worth AP (2019). The history of alternative test methods in toxicology. London: Academic Press. ISBN 978-0-12-813698-0. OCLC 1057893426.
  35. ^ van Leeuwen CJ, Vermeire TG (2007). Risk assessment of chemicals: An introduction. New York: Springer. pp. 451–479. ISBN 978-1-4020-6102-8.
  36. National Research Council (2007). Toxicity Testing in the 21st Century: A Vision and a Strategy. National Academies Press. ISBN 978-0-309-15173-3. Lay summary Archived 2020-02-15 at the Wayback Machine
  37. Krewski D, Acosta D, Andersen M, Anderson H, Bailar JC, Boekelheide K, et al. (February 2010). "Toxicity testing in the 21st century: a vision and a strategy". Journal of Toxicology and Environmental Health Part B: Critical Reviews. 13 (2–4): 51–138. Bibcode:2010JTEHB..13...51K. doi:10.1080/10937404.2010.483176. PMC 4410863. PMID 20574894.
  38. Zurlinden TJ, Saili KS, Rush N, Kothiya P, Judson RS, Houck KA, et al. (April 2020). "Profiling the ToxCast Library With a Pluripotent Human (H9) Stem Cell Line-Based Biomarker Assay for Developmental Toxicity". Toxicological Sciences. 174 (2): 189–209. doi:10.1093/toxsci/kfaa014. PMC 8527599. PMID 32073639.
  39. Adler S, Basketter D, Creton S, Pelkonen O, van Benthem J, Zuang V, et al. (May 2011). "Alternative (non-animal) methods for cosmetics testing: current status and future prospects-2010". Archives of Toxicology. 85 (5): 367–485. doi:10.1007/s00204-011-0693-2. PMID 21533817. S2CID 28569258.
  40. Ottoboni 1991, pp. 83–85.
  41. Patlewicz G, Worth A, Yang C, Zhu T (2022). "Editorial: Advances and Refinements in the Development and Application of Threshold of Toxicological Concern". Frontiers in Toxicology. 4: 882321. doi:10.3389/ftox.2022.882321. PMC 9096208. PMID 35573274.
  42. Talhout R, Schulz T, Florek E, van Benthem J, Wester P, Opperhuizen A (February 2011). "Hazardous compounds in tobacco smoke". International Journal of Environmental Research and Public Health. 8 (2): 613–628. doi:10.3390/ijerph8020613. PMC 3084482. PMID 21556207.
  43. Dinis-Oliveira RJ, Carvalho F, Duarte JA, Remião F, Marques A, Santos A, et al. (September 2010). "Collection of biological samples in forensic toxicology". Toxicology Mechanisms and Methods. 20 (7): 363–414. doi:10.3109/15376516.2010.497976. PMID 20615091. S2CID 20779037.
  44. Reisfeld B, Mayeno AN (2012). "What is Computational Toxicology?". Computational Toxicology. Methods in Molecular Biology. Vol. 929. pp. 3–7. doi:10.1007/978-1-62703-050-2_1. ISBN 978-1-62703-049-6. PMID 23007423.
  45. Hartung T (May 2009). "A toxicology for the 21st century--mapping the road ahead". Toxicological Sciences. 109 (1): 18–23. doi:10.1093/toxsci/kfp059. PMC 2675641. PMID 19357069.
  46. Berg N, De Wever B, Fuchs HW, Gaca M, Krul C, Roggen EL (June 2011). "Toxicology in the 21st century--working our way towards a visionary reality". Toxicology in Vitro. 25 (4): 874–881. Bibcode:2011ToxVi..25..874B. doi:10.1016/j.tiv.2011.02.008. PMID 21338664.
  47. "Toxicology in the 21st century Data Challenge". www.tripod.nih.gov.
  48. "NCATS Announces Tox21 Data Challenge Winners". www.ncats.nih.gov. Archived from the original on 2015-02-28.
  49. Unterthiner T, Mayr A, Klambauer G, Steijaert M, Wegner JK, Ceulemans H, et al. (December 2014). Deep learning as an opportunity in virtual screening (PDF). Proceedings of the deep learning workshop at NIPS. Vol. 27. pp. 1–9.
  50. Unterthiner T, Mayr A, Klambauer G, Hochreiter S (March 2015). "Toxicity prediction using deep learning". arXiv:1503.01445 .
  51. Johnson BL (January 1983). "Occupational Toxicology: NIOSH Perspective". Journal of the American College of Toxicology. 2 (1): 43–50. doi:10.3109/10915818309140666. ISSN 0730-0913. S2CID 84847131.
  52. "Toxicology Overview". American Chemical Society. Retrieved 10 May 2020.
  53. "Biological Scientists". U.S. Bureau of Labor Statistics. Retrieved 15 Dec 2023.

Further reading

  • Caito S, Lopes AC, Paoliello MM, Aschner M (2017). "Chapter 16. Toxicology of Lead and Its Damage to Mammalian Organs". In Astrid S, Helmut S, Sigel RK (eds.). Lead: Its Effects on Environment and Health. Metal Ions in Life Sciences. Vol. 17. de Gruyter. pp. 501–534. doi:10.1515/9783110434330-016. ISBN 978-3-11-043433-0. PMID 28731309.
  • Andresen E, Küpper H (2013). "Cadmium Toxicity in Plants". In Sigel A, Sigel H, Sigel RK (eds.). Cadmium: From Toxicity to Essentiality. Metal Ions in Life Sciences. Vol. 11. Springer. pp. 395–413. doi:10.1007/978-94-007-5179-8_13. ISBN 978-94-007-5178-1. PMID 23430780. (subscription required)
  • Thévenod F, Lee WK (2013). "Toxicology of Cadmium and Its Damage to Mammalian Organs". In Sigel A, Sigel H, Sigel RK (eds.). Cadmium: From Toxicity to Essentiality. Metal Ions in Life Sciences. Vol. 11. Springer. pp. 415–490. doi:10.1007/978-94-007-5179-8_14. ISBN 978-94-007-5178-1. PMID 23430781. (subscription required)

External links

Toxicology
Fields
Concepts
Treatments
Incidents
Related topics
Inorganic
Metals
Toxic metals
Dietary minerals
Other non-toxic metals
Metalloids
Nonmetals
Organic
Phosphorus
Nitrogen
CHO
Pharmaceutical
Drug overdoses
Nervous
Cardiovascular
Vitamin poisoning
Biological
Fish / Seafood
Other vertebrates
Arthropods
Plants / Fungi
Related topics
Miscellaneous
Silver is generally non-toxic metal, but in large doses it can lead to argyria, which is rare.
including venoms, toxins, foodborne illnesses.
Pharmacology
Ligand (biochemistry)
Excitatory
Inhibitory
Pharmacodynamics
Activity at receptor
  • Mechanism of action
  • Mode of action
  • Binding
  • Receptor (biochemistry)
  • Desensitization (medicine)
  • Other effects of ligand
    Analysis
    Metrics
    Pharmacokinetics
    Metrics
    LADME
    Related
    fields
    Neuroscience and psychology
  • Neuropsychopharmacology
  • Neuropharmacology
  • Psychopharmacology
  • Electrophysiology
  • Medicine
    Biochemistry and genetics
    Toxicology
    Drug discovery
    Other
  • Coinduction (anesthetics)
  • Combination therapy
  • Functional analog (chemistry)
  • Polypharmacology
  • Chemotherapy
  • Lists of drugs
  • WHO list of essential medicines
  • Tolerance and resistance
    Antimicrobial pharmacology
    Pharmacy
    General
    Pharmaceutical sciences
    Professions
    Practice areas
    Pharmaceutical industry
    Branches of biology
    See also
    Category: